AKT1 and intrahepatic cholangiocarcinoma: Separate or combined OSM and IL-11 treatments did not significantly affect Akt, ERK1/2, p38 MAPK, JNK or p65 phosphorylation in the ICC cell lines (online supplemental figure 6).